Normalized creatinine-to-cystatin C ratio and cardiovascular disease risk in populations with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a national and prospective cohort study

Abstract Background The normalized creatinine-to-cystatin C ratio (NCCR) has been identified as a viable metric for assessing skeletal muscle mass and diabetes risk. However, the relationship between NCCR and cardiovascular disease (CVD) remains insufficiently understood. This study aims to clarify...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Defei Chen, Yuhui Li, Tailin Ran, Fu Song, Zheng Yang, Weilin Tan, Qiuyi Lu, Lanxin Tang, Lining Yang, Dingqun Bai
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2026-01-01
Seri Bilgileri:	European Journal of Medical Research
Konular:	Cardiovascular disease Cardiovascular–kidney–metabolic syndrome CHARLS Creatinine-to-cystatin C ratio
Online Erişim:	https://doi.org/10.1186/s40001-026-03905-z
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!